The Rational Design of Specific Peptide Inhibitor against p38α MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC
- Type
- Retraction
- Notice date
- 12/8/2023 0:00
- Journal
- PLoS One
- Publisher
- PLoS
- Notice DOI
- 10.1371/journal.pone.0295637
- Original paper DOI
- 10.1371/journal.pone.0101525